Paragraph 1
The modifications of the 2013 Regulations referred to in regulation 16 are that those Regulations are to be read as if—
in regulation 2 (interpretation)—
in the definition of “resident patient”, for “the United Kingdom is” there were substituted “immediately before exit day the United Kingdom was”;
in the definition of “visiting patient”, for “a member State other than the United Kingdom is” there were substituted “immediately before exit day a member State other than the United Kingdom was”;
in the heading to regulation 5 (national contact point: information about treatment in another member State), for “another member State” there were substituted “a member State”;
in regulation 5—
for references to “other member States” there were substituted “member States”;
for the reference to “another member State” there were substituted “a member State”;
regulation 5A (National Contact Point: information about prescriptions intended to be used in another member State) were omitted;
for regulation 6(1) (National Contact Point: cross-border co-operation) there were substituted—
“(1)In so far as it considers it appropriate for the purposes of giving effect to regulation 16 of the National Health Service (Cross-Border Healthcare and Miscellaneous Amendments etc) (EU Exit) Regulations 2019, the NCP must co-operate with the national contact points in member States and any other national contact points established in the United Kingdom.”;
regulation 7 (National Contact Point: duty to consult) were omitted;
in regulation 12—
in paragraph (2) for “P is” there were substituted “immediately before exit day P was”;
in paragraph (2)(a), for “is resident” there were substituted “was resident”;
in paragraph (2)(b), for “is the competent member State” there were substituted “was the competent member State”;
in paragraph (4)(b) at the end there were inserted “as it had effect immediately before exit day”;
the schedule (elements that must be included in prescriptions intended to be used in another member State) were omitted.